2023-08-29 07:18:39
Mainz/New York/Cambridge – The US pharmaceutical company Pfizer and its German partner BioNTech are applying for the cancellation of Moderna’s patents on the corona vaccination technology in the USA. The two patents are “unimaginably general” and cover a basic idea that has been “known for a long time,” the vaccine manufacturers said on Monday before the US Patent Office’s Board of Appeal. The drugmakers also filed opposition to a third, related Moderna patent.
1693293677
#Pfizer #BioNTech #Challenge #Moderna #Patents #Corona #Vaccine #Health